Abstract
Non-invasive aerosol therapy of surface-active lipopolymeric nanohybrids co-delivers two drugs in inflamed lungs and also replenishes the depleted lung surfactant pool in inflamed alveoli following cellular uptake by the cells.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have